Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.

Nina ShahA Megan CornelisonRima SalibaSairah AhmedYago L NietoQaiser BashirSimrit ParmarChitra HosingUday PopatElizabeth J ShpallRichard E ChamplinMuzaffar Qazilbash

Published in: European journal of haematology (2017)

Outpatient auto-HCT can be safely performed for selected patients with MM. Differences in outcomes are likely related to baseline clinical characteristics rather than choice of treatment setting.

Keyphrases

multiple myeloma
bone marrow
acute myeloid leukemia
mental health
palliative care
cell therapy
stem cells
metabolic syndrome
platelet rich plasma
signaling pathway
adipose tissue
mesenchymal stem cells
decision making
drug induced